I don't have the BERD numbers in front of me. I assume that's what you are quoting. R and D tends to vary from industry to industry. If you look at pharmaceuticals, it's 10% of the revenues. For other industries it's a very tiny share.
We can certainly look at whether they can spend more. That's a valid policy question. I don't really have an answer for it.